Not applicableStudy completedNCT02752178What this trial is testingPeripheral Immunomarker Validation in Treatment-resistant DepressionWho this might be right forDepressive Disorder, Major University of Cambridge 393
Post-approval studies (Phase 4)Study completedNCT00231959What this trial is testingEffectiveness of Pramipexole for Treatment-Resistant DepressionWho this might be right forDepression Massachusetts General Hospital 65
Not applicableStudy completedNCT01507155What this trial is testingAn Open Label Study of Clinical Utility and Patient Outcomes of the Genecept AssayWho this might be right forTreatment Resistant DepressionGeneralized Anxiety Disorder Genomind, LLC 685
Large-scale testing (Phase 3)UnknownNCT01450150What this trial is testingTranscranial Direct Current Stimulation as an Augmenting Intervention for Major DepressionWho this might be right forMajor Depressive Disorder Douglas Mental Health University Institute 30
Testing effectiveness (Phase 2)Study completedNCT02456948What this trial is testingAdjunct Minocyline in Treatment-resistant DepressionWho this might be right forMajor Depressive Disorder Charite University, Berlin, Germany 168
Not applicableStudy completedNCT00533832What this trial is testingPivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD)Who this might be right forMajor Depressive Disorder Cyberonics, Inc. 266
Not applicableTemporarily pausedNCT06013384What this trial is testingLow-Intensity Focused Ultrasound for Treatment-Resistant DepressionWho this might be right forMajor Depressive DisorderTreatment Resistant Depression Medical University of South Carolina 1
Not applicableLooking for participantsNCT07528014What this trial is testingATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1Who this might be right forDepressed Mood Salma Health, Inc. 5,000
Not applicableEnded earlyNCT00715559What this trial is testingCysteamine Therapy for Major Depressive DisorderWho this might be right forMajor Depressive Disorder Icahn School of Medicine at Mount Sinai 3
Post-approval studies (Phase 4)Looking for participantsNCT07680140What this trial is testingBiomarker-Guided Antidepressant SelectionWho this might be right forDepression - Major Depressive DisorderTreatment-resistant Depression (TRD)rTMS+2 more Weill Medical College of Cornell University 27
Testing effectiveness (Phase 2)Study completedNCT05324735What this trial is testingPentoxifylline for Treatment of Resistant Major DepressionWho this might be right forResistant Major Depression Hawler Medical University 60
Early research (Phase 1)Study completedNCT04226352What this trial is testingThree Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive DisorderWho this might be right forMDDTreatment Resistant DepressionSmoking Cessation+1 more Johns Hopkins University 5
Testing effectiveness (Phase 2)Study completedNCT01234558What this trial is testingSingle IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionWho this might be right forMajor Depressive Disorder Naurex, Inc, an affiliate of Allergan plc 115
Not applicableUnknownNCT01768052What this trial is testingFunctional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major DepressionWho this might be right forMajor Depression Mclean Hospital 40
Not applicableEnded earlyNCT04078438What this trial is testingNeurofeedback In Treatment Resistant DepressionWho this might be right forDepressionNeurofeedback Yeungnam University Hospital 70
Testing effectiveness (Phase 2)Study completedNCT01644747What this trial is testingTDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar PatientsWho this might be right forResistant DepressionMoods DisordersUnipolar Depression+1 more Centre Hospitalier Universitaire de Besancon 87
Testing effectiveness (Phase 2)Study completedNCT03051256What this trial is testingSafety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDDWho this might be right forDepressive Disorder, MajorDepressive Disorder, Treatment-Resistant Relmada Therapeutics, Inc. 62
Early research (Phase 1)Ended earlyNCT00380042What this trial is testingAssessment of the Safety and Effectiveness of Cortical Stimulation in Subjects With Major Depressive DisorderWho this might be right forDepressionDepressive Disorder Northstar Neuroscience 12
Not applicableLooking for participantsNCT06620276What this trial is testingACT_for Alcohol Use Disorder and DepressionWho this might be right forDepression - Major Depressive DisorderAlcohol Use Disorder Centre hospitalier de l'Université de Montréal (CHUM) 30
Not applicableNot Yet RecruitingNCT06748950What this trial is testingKetogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingWho this might be right forSchizophreniaSchizophrenia and Related DisordersBipolar Disorder+7 more Stanford University 120